These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 18385267

  • 1. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA, Viney RL, Saleem MA, Ladomery MR.
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [Abstract] [Full Text] [Related]

  • 2. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW, Morison IM, Gubler MC, Corbett R, Reeve AE.
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [Abstract] [Full Text] [Related]

  • 3. Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome.
    Dahan K, Kamal M, Noël LH, Jeanpierre C, Gubler MC, Brousse N, Mariaud de Serre NP.
    Am J Kidney Dis; 2007 Jun; 49(6):793-800. PubMed ID: 17533022
    [Abstract] [Full Text] [Related]

  • 4. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE, Fleming S, Miles CG, Bellamy CO, Ladomery M, Spraggon L, Mullins J, Hastie ND, Hooper ML.
    Hum Mol Genet; 2003 Sep 15; 12(18):2379-94. PubMed ID: 12915483
    [Abstract] [Full Text] [Related]

  • 5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 6. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC.
    Am J Pathol; 1999 Jan 17; 154(1):181-92. PubMed ID: 9916932
    [Abstract] [Full Text] [Related]

  • 7. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
    Barbaux S, Niaudet P, Gubler MC, Grünfeld JP, Jaubert F, Kuttenn F, Fékété CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K.
    Nat Genet; 1997 Dec 17; 17(4):467-70. PubMed ID: 9398852
    [Abstract] [Full Text] [Related]

  • 8. Wilms tumor and the WT1 gene.
    Lee SB, Haber DA.
    Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525
    [Abstract] [Full Text] [Related]

  • 9. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec 10; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 10. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
    Chiang PW, Aliaga S, Travers S, Spector E, Tsai AC.
    Curr Opin Pediatr; 2008 Feb 10; 20(1):103-6. PubMed ID: 18197048
    [Abstract] [Full Text] [Related]

  • 11. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
    Schumacher VA, Jeruschke S, Eitner F, Becker JU, Pitschke G, Ince Y, Miner JH, Leuschner I, Engers R, Everding AS, Bulla M, Royer-Pokora B.
    J Am Soc Nephrol; 2007 Mar 10; 18(3):719-29. PubMed ID: 17267748
    [Abstract] [Full Text] [Related]

  • 12. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C, Schedl A.
    J Am Soc Nephrol; 2000 Nov 10; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [Abstract] [Full Text] [Related]

  • 13. Insights into the physiological role of WT1 from studies of genetically modified mice.
    Discenza MT, Pelletier J.
    Physiol Genomics; 2004 Feb 13; 16(3):287-300. PubMed ID: 14966251
    [Abstract] [Full Text] [Related]

  • 14. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA, Liu J, Eremina V, Hodgens K, Li C, Hamano Y, Mundel P, Kalluri R, Miner JH, Quaggin SE, Kreidberg JA.
    J Am Soc Nephrol; 2002 Aug 13; 13(8):2058-67. PubMed ID: 12138137
    [Abstract] [Full Text] [Related]

  • 15. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
    Dong L, Pietsch S, Tan Z, Perner B, Sierig R, Kruspe D, Groth M, Witzgall R, Gröne HJ, Platzer M, Englert C.
    J Am Soc Nephrol; 2015 Sep 13; 26(9):2118-28. PubMed ID: 25556170
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
    Hakan N, Aydin M, Erdogan O, Cavusoglu YH, Aycan Z, Ozaltin F, Zenciroglu A, Apaydin S, Gunes R, Sahin G, Cinar G, Okumus N.
    Genet Couns; 2012 Sep 13; 23(2):255-61. PubMed ID: 22876585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.